Granite Point Capital Management, L.P. - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 62 filers reported holding RECRO PHARMA INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Granite Point Capital Management, L.P. ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q4 2017$352,000
+3.2%
38,0000.0%0.03%
-52.8%
Q3 2017$341,000
+27.7%
38,0000.0%0.07%
+9.1%
Q2 2017$267,000
-53.4%
38,000
-42.0%
0.07%
-61.4%
Q1 2017$573,000
-6.5%
65,550
-13.8%
0.17%
-65.0%
Q4 2016$613,000
-3.6%
76,000
+5.6%
0.49%
+97.2%
Q3 2016$636,00072,0000.25%
Other shareholders
RECRO PHARMA INC shareholders Q3 2017
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders